Literature DB >> 29603814

Prevalence and factors associated with polypharmacy in the older people: 2006-2014.

Juan Manuel Carmona-Torres1,2, Ana Isabel Cobo-Cuenca1,2, Beatriz Recio-Andrade3, José Alberto Laredo-Aguilera4, María Manuela Martins5, María Aurora Rodríguez-Borrego2,6,7.   

Abstract

AIMS AND
OBJECTIVES: To analyse the prevalence, risk factors and evolution over time of polypharmacy and self-medication in the older people in Spain from 2006-2014.
BACKGROUND: Polypharmacy is a public health problem for older people worldwide which causes different negative effects on their health, increasing health costs and pharmaceutical spending. However, previous studies do not include nationally representative samples and none of them provide updated data.
DESIGN: Cross-sectional study with community-dwelling older adults (N = 26,277) who participated in the National Health Survey in Spain in 2006 and 2011/2012 and the European Health Survey in Spain in 2009 and 2014.
METHODS: Polypharmacy (defined as use of five or more medications in the last 2 weeks), excessive polypharmacy (defined as use of ten or more medications in the last 2 weeks) and self-medication (defined as use of medications without a prescription) were evaluated. A logistic regression was used for to know the association between polypharmacy and self-medication with the sociodemographic characteristic.
RESULTS: The participants were 62% female and 38% male. The mean medication consumption was 2.96 (SD ± 2.11). Prevalence of polypharmacy was present in 21.9%, prevalence of excessive polypharmacy was 0.6%, and prevalence of self-medication was 10.7%. The most commonly used medications were for blood pressure (51.6%), pain (42.8%) and cholesterol (28.2%). Polypharmacy is associated with sex (females), age, being separated/divorced/widowed, lack of education, higher body mass index, being bedridden during the last 2 weeks and self-medication.
CONCLUSIONS: The prevalence of polypharmacy and prevalence of self-medication are considerable, and they increased significantly from 2006-2014. RELEVANCE TO CLINICAL PRACTICE: To deal with polypharmacy is a big challenge for nurses. These data suggest to establish innovative clinical strategies in which the health professionals and the patients are involved to improve the personal behaviour with medicines and to reduce the risks and costs of polypharmacy and self-medication.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Spain; aged; medication; polypharmacy; public health; self-medication

Mesh:

Year:  2018        PMID: 29603814     DOI: 10.1111/jocn.14371

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  13 in total

1.  Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data.

Authors:  Naser Kamyari; Ali Reza Soltanian; Hossein Mahjub; Abbas Moghimbeigi; Zahra Shahali
Journal:  Med J Islam Repub Iran       Date:  2021-12-27

2.  Association of personality traits with polypharmacy among community-dwelling older adults in Japan: a cross-sectional analysis of data from the SONIC study.

Authors:  Yuko Yoshida; Tatsuro Ishizaki; Yukie Masui; Yasumichi Arai; Hiroki Inagaki; Madoka Ogawa; Saori Yasumoto; Hajime Iwasa; Kei Kamide; Hiromi Rakugi; Kazunori Ikebe; Yasuyuki Gondo
Journal:  BMC Geriatr       Date:  2022-04-28       Impact factor: 4.070

3.  Prevalence and Risk of Polypharmacy among Community-Dwelling, Elderly Kuwaiti Patients.

Authors:  Nabil Ahmed Badawy; Shokria Adely Labeeb; Mawaheb Falah Alsamdan; Badria Faleh Alazemi
Journal:  Med Princ Pract       Date:  2019-09-11       Impact factor: 1.927

4.  Changes in Alcohol Consumption and Associated Variables among Older Adults in Spain: A population-based cohort study.

Authors:  Hosanna Soler-Vila; Rosario Ortolá; Esther García-Esquinas; Luz Mª León-Muñoz; Fernando Rodríguez-Artalejo
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

5.  Adverse drug events and the associated factors in patients with chronic Chagas disease.

Authors:  Luiza Braz da Cunha Lopes; Raquel Rodrigues Pereira; Patricia Mello Andrade; Fernanda Martins Carneiro; Mauro Felippe Felix Mediano; Sophia Isabel Linnemann Kilgore; Alejandro Marcel Hasslocher-Moreno; Andréa Silvestre de Sousa; Manoel Marques Evangelista Oliveira; Roberto Magalhães Saraiva; Marcelo Teixeira de Holanda; Gilberto Marcelo Sperandio da Silva
Journal:  Rev Soc Bras Med Trop       Date:  2020-04-22       Impact factor: 1.581

6.  Medication Consumption Patterns and Polypharmacy among Community-Dwelling Elderly in Lomé (Togo) in 2017.

Authors:  Fifonsi A Gbeasor-Komlanvi; Wendpouiré I C Zida-Compaore; Ikpindi H Dare; Aboudoulatif Diallo; Tchin P Darre; Yao Potchoo; Mofou Belo; Didier K Ekouevi
Journal:  Curr Gerontol Geriatr Res       Date:  2020-01-09

7.  Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.

Authors:  Ayman Al-Dahshan; Noora Al-Kubiasi; Manal Al-Zaidan; Wael Saeed; Vahe Kehyayan; Iheb Bougmiza
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

8.  Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens.

Authors:  Przemysław Kardas; Filip Urbański; Aneta Lichwierowicz; Ewa Chudzyńska; Grzegorz Kardas; Marcin Czech
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

9.  Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan.

Authors:  Toshiki Suzuki; Masao Iwagami; Shota Hamada; Tomoyuki Matsuda; Nanako Tamiya
Journal:  BMC Health Serv Res       Date:  2020-04-26       Impact factor: 2.655

10.  Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study).

Authors:  M Rosa Dalmau Llorca; Carina Aguilar Martín; Noèlia Carrasco-Querol; Zojaina Hernández Rojas; Emma Forcadell Drago; Dolores Rodríguez Cumplido; Elisabet Castro Blanco; Alessandra Queiroga Gonçalves; José Fernández-Sáez
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.